I-Mab Eulerpool News

I-Mab Stock News

I-Mab is being monitored by journalists and investors worldwide. We gather the latest I-Mab news here.

• September 10 ·

  SeekingAlpha
  I-Mab: Sudden Pivot To Gastric Cancer Med Still Underappreciated By Market
• August 11 ·

  Yahoo
  I-Mab Completes Enrollment in Planned Phase 1b Dose Expansion Study for Givastomig in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers
• August 1 ·

  Yahoo
  Everest Medicines Expands Strategic Investment in I-MAB
• July 14 ·

  Yahoo
  I-Mab to Present at the BTIG Virtual Biotechnology Conference
• July 9 ·

  Yahoo
  I-Mab Presents Promising Phase 1b Givastomig Combination Data for Gastric Cancers at ESMO GI 2025
• June 18 ·

  Yahoo
  I-Mab to Host Webinar to Recap New Givastomig Data, in Combination with Immunochemotherapy, Expected at ESMO GI 2025
• June 12 ·

  Yahoo
  I-Mab Regains Compliance with Nasdaq Minimum Bid Price Requirement
• June 3 ·

  Yahoo
  I-Mab to Participate in the H.C. Wainwright “HCW@Home” Series
• April 30 ·

  Yahoo
  I-Mab Announces Givastomig Abstract Accepted for Oral Presentation at ESMO GI 2025
• February 4 ·

  Yahoo
  I-Mab to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference